WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
P.O.Box 4404 Nydalen
0403 Oslo
Norway

Visiting/delivery address:
Marcus Thranes gate 6
0473 Oslo
Norway

Tel:  +47 21 07 81 60
Fax: +47 21 07 81 46
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

N NERVOUS SYSTEM
N05 PSYCHOLEPTICS

The group is divided into therapeutic subgroups:

N05A - Antipsychotics
N05B - Anxiolytics
N05C - Hypnotics and sedatives


N05C HYPNOTICS AND SEDATIVES

This group comprises preparations with mainly sedative or hypnotic actions.

See also:
N05A - Antipsychotics
N05B - Anxiolytics
R06A - Antihistamines for systemic use

Combined preparations are classified at separate 4th levels, N05CB and N05CX.

Regarding classification of combined preparations, see comments under N05B - Anxiolytics.

Combined preparations with barbiturates are mainly classified in A03 (mainly antispasmodic effect) or in N02 (mainly analgesic effect).
Combined preparations with barbiturates which remain in N05C are mainly "neurostabilizers".

The group is subdivided according to chemical structure.

The DDDs are based on use of the drugs as hypnotics.

The DDD for melatonin is based on dose recommendations in EU for the 2 mg depot tablet.


N05CC Aldehydes and derivatives

List of abbreviations

Last updated: 2013-12-19